Treatment options for chronic rhinosinusitis

Proceedings of the American Thoracic Society

Volumn 8, Issue 1, 2011, Pages 132-140

  Suh, Jeffrey D ^a   Kennedy, David W ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Chronic rhinosinusitis; CRS; Management; Sinus surgery

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTIHISTAMINIC AGENT; AZELASTINE; BUDESONIDE; CIPROFLOXACIN; CLARITHROMYCIN; CLINDAMYCIN; CORTICOSTEROID; COTRIMOXAZOLE; DECONGESTIVE AGENT; ERYTHROMYCIN; GENTAMICIN; GUAIFENESIN; HISTAMINE H1 RECEPTOR ANTAGONIST; ITRACONAZOLE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LEVOFLOXACIN; MACROLIDE; MUCOLYTIC AGENT; PREDNISOLONE; PSEUDOMONIC ACID; ROXITHROMYCIN; SODIUM CHLORIDE; TERBINAFINE; TOBRAMYCIN; ANTIINFECTIVE AGENT; STEROID;

ADVERSE DRUG REACTION; ALLERGIC ASTHMA; ALLERGIC RHINITIS; ANTIBIOTIC THERAPY; BACTERIAL INFECTION; BRONCHIOLITIS; CHRONIC DISEASE; CHRONIC RHINOSINUSITIS; CLINICAL EFFECTIVENESS; CONFERENCE PAPER; CORTICOSTEROID THERAPY; CRUSTING; DISEASE PREDISPOSITION; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG ERUPTION; DRUG INDUCED HEADACHE; DRUG MEGADOSE; DRUG SAFETY; EAR NOSE THROAT SURGERY; EDEMA; ENDOSCOPY; EPISTAXIS; FATIGUE; HUMAN; LIVER FUNCTION TEST; LOW DRUG DOSE; LUNG ASPERGILLOSIS; MALAISE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; NASAL LAVAGE; NAUSEA; NOSE IRRITATION; NOSE POLYP; NOSE SEPTUM; PATHOPHYSIOLOGY; PRURITUS; RHINITIS; RHINORRHEA; RHINOSINUSITIS; SIDE EFFECT; TREATMENT RESPONSE; COMPARATIVE STUDY; DRUG EFFECT; FEMALE; HOSPITALIZATION; INHALATIONAL DRUG ADMINISTRATION; LAVAGE; MALE; METHODOLOGY; MUCOCILIARY CLEARANCE; PHYSIOLOGY; PROGNOSIS; REVIEW; RISK ASSESSMENT; SINUSITIS; TOPICAL DRUG ADMINISTRATION; TREATMENT OUTCOME;

ADMINISTRATION, INHALATION; ADMINISTRATION, TOPICAL; ANTI-BACTERIAL AGENTS; CHRONIC DISEASE; FEMALE; HISTAMINE ANTAGONISTS; HUMANS; MALE; MUCOCILIARY CLEARANCE; OTORHINOLARYNGOLOGIC SURGICAL PROCEDURES; PROGNOSIS; RHINITIS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SINUSITIS; STEROIDS; THERAPEUTIC IRRIGATION; TREATMENT OUTCOME;

EID: 79960637982     PISSN: 15463222     EISSN: 19435665     Source Type: Journal    
DOI: 10.1513/pats.201003-028RN     Document Type: Conference Paper

References (95)

1. Benninger MS, Ferguson BJ, Hadley JA. Adult chronic rhinosinusitis: definitions, diagnosis, epidemoiology, and pathophysiology. Otolaryngol Head Neck Surg 2003;129:S1-S32.
2. Rosenfeld RM, Andes D, Bhattacharyya N, Cheung D, Eisenberg S, Ganiats TG, Gelzer A, Hamilos D, Haydon RC 3rd, Hudgins PA, et al. Clinical practice guidelines on adult sinusitis. Otolaryngol Head Neck Surg 2007;137:375-377.
3. Meltzer EO, Hamilos DL, Hadley JA. Rhinosinusitis: establishing definitions for clinical research and patient care. Otolaryngol Head Neck Surg 2004;131:S1-S62. (Pubitemid 39577605)
4. Marple BF, Stankiewicz JA, Baroody FM, Chow JM, Conley DB, Corey JP, Ferguson BJ, Kern RC, Lusk RP, Naclerio RM, et al. Diagnosis and management of chronic rhinosinusitis in adults. Postgrad Med 2009;121:121-139.
5. Benninger MS, Anon J, Mabry RL. The medical management of rhinosinusitis. Otolaryngol Head Neck Surg 1997;117:S41-S49. (Pubitemid 27435428)
6. Lund VJ. Maximal medical therapy for chronic rhinosinusitis. Otolaryngol Clin North Am 2005;38:1301-1310. (Pubitemid 41737839)
7. Grzincich G, Capra L, Cammarata MG, Spaggiari C, Pisi G. Effectiveness of intranasal corticosteroids. Acta Biomed. 2004;75:22-25.
8. Gillespie MB, Osguthorpe JD. Pharmacologic management of chronic rhinosinusitis, alone or with nasal polyposis. Curr Allergy Asthma Rep 2004;4:478-485. (Pubitemid 39585684)
9. Derendorf H, Meltzer EO. Molecular and clinical pharmacology of intranasal corticosteroids: clinical and therapeutic implications. Allergy 2008;63:1292-1300.
10. Badia L, Lund V. Topical corticosteroids in nasal polyposis. Drugs 2001;61:573-578. (Pubitemid 32453369)
11. Langrick AF. Comparison of flunisolide and beclomethasone dipropionate in seasonal allergic rhinitis. Curr Med Res Opin 1984;9:290-295.
12. Statham MM, Seiden A. Potential new avenues of treatment for chronic rhinosinusitis: an anti-inflammatory approach. Otolaryngol Clin North Am 2005;38:1351-1365. (Pubitemid 41737843)
13. Dingsor G, Kramer J, Olsholt R, Soderstrom T. Flunisolide nasal spray 0.025% in the prophylactic treatment of nasal polyposis after polypectomy. A randomized, double blind, parallel, placebo controlled study. Rhinology 1985;23:49-58.
14. Kalish LH, Arendts G, Sacks R, Craig JC. Topical steroids in chronic rhinosinusitis without polyps: a systemic review and meta-analysis. Otolaryngol Head Neck Surg 2009;141:674-683.
15. DeMarcantonio MA, Han JK. Systemic therapies in managing sinonasal inflammation. Otolaryngol Clin North Am 2010;43:551-563, ix.
16. Lennard CM, Mann EA, Sun LL, Chang AS, Bolger WE. Interleukin-1 beta, interleukin-5, interleukin-6, interleukin-8, and tumor necrosis factor-alpha in chronic sinusitis: response to systemic corticosteroids. Am J Rhinol 2000;14:367-373. (Pubitemid 32331909)
17. Van Camp C, Clement PA. Results of oral steroid treatment in nasal polyposis. Rhinology 1994;32:5-9. (Pubitemid 24133848)
18. Woodworth BA, Joseph K, Kaplan AP, Schlosser RJ. Alterations in eotaxin, monoctye chemoattractant protein-4, interleukin-5, and interleukin-13 after systemic steroid treatment for nasal polyps. Otolaryngol Head Neck Surg 2004;131:585-589. (Pubitemid 39446279)
19. Piccirillo JF, Merritt MG Jr, Richards ML. Psychometric and clinimetric validity of the 20-item sino-nasal outcome test (SNOT-20). Otolaryngol Head Neck Surg 2002;126:41-47. (Pubitemid 41122866)
20. Hissaria P, Smith W, Wormald PJ, Taylor J, Vadas M, Gillis D, Kette F. Short course of systemic corticosteroids in sinonasal polyposis: a double-blind, randomized, placebo-controlled trial with evaluation of outcome measures. J Allergy Clin Immunol 2006;118:128-133. (Pubitemid 43946470)
21. Bachmann G, Hommel G, Michel OL. Effect of irrigation of the nose with isotonic salt solution on adult patients with chronic paranasal sinus disease. Eur Arch Otorhinolaryngol 2000;257:537-541. (Pubitemid 32009705)
22. Harvey R, Hannan SA, Badia L, Scadding G. Nasal saline irrigations for the symptoms of chronic rhinosinusitis. Cochrane Database Syst Rev 2007; (3):1-37.
23. Harvey RJ, Schlosser RJ. Local drug delivery. Otolaryngol Clin North Am 2009;42:829-845.
24. Rabago D, Zgierska A, Mundt M, Barrett B, Bobula J, Maberry R. Efficacy of daily hypertonic saline nasal irrigation among patients with sinusitis: a randomized controlled trial. J Fam Pract 2002;51:1049-1055. (Pubitemid 35453622)
25. Rabago D, Pasic T, Zgierska A, Mundt M, Barrett B, Maberry R. The efficacy of hypertonic saline nasal irrigation for chronic sinonasal symptoms. Otolaryngol Head Neck Surg 2005;133:3-8. (Pubitemid 40980953)
26. Talbot AR, Herr TM, Parsons DS. Mucociliary clearance and buffered hypertonic saline solution. Laryngoscope 1997;107:500-550.
27. Hauptman G, Ryan MW. The effect of saline solutions on patiency and mucociliary clearance in rhinosinusitis patients. Otolaryngol Head Neck Surg 2007;137:815-821. (Pubitemid 47632936)
28. Tomooka LT, Murphy C, Davidson TM. Clinical study and literature review of nasal irrigation. Laryngoscope 2000;110:1189-1193. (Pubitemid 30439780)
29. Sachanandani NS, Piccirillo JF, Kramper MA, Thawley SE, Vlahiotis A. The effect of nasally administered budesonide respules on adrenal cortex function in patients with chronic rhinosinusitis. Arch Otolaryngol Head Neck Surg 2009;135:303-307.
30. Steinke JW, Payne SC, Tessier ME, Borish LO, Han JK, Borish LC. Pilot study of budesonide inhalant suspension for chronic eosinophilic sinusitis. J Allergy Clin Immunol 2009;124:1352-1354.
31. Bhalla RK, Payton K, Wright ED. Safety of budesonide in saline sinonasal irrigations in the management of chronic rhinosinusitis with polyposis: lack of significant adrenal suppression. J Otolaryngol Head Neck Surg 2008;37:821-825.
32. Yu C, Chen FDY, Wang J, Gu YJ, Gao X. Effect of Pulmicort Respule on rehabilitation after functional endoscopic sinus surgery. Acta Chimi Sin 2007;21:100-102.
33. Leonard DW, Bolger WE. Topical antibiotic therapy for recalcitrant sinusitis. Laryngoscope 1999;109:668-670. (Pubitemid 29165925)
34. Araujo E, Palombini BC, Cantarelli V, Pereira A, Mariante A. Microbiology of middle meatus in chronic rhinosinusitis. Am J Rhinol 2003;17:9-15. (Pubitemid 36395381)
35. Chiu AG, Antunes MB, Palmer JN, Cohen NA. Evaluation of the in vivo efficacy of topical tobramycin against Pseudomonas sinonasal biofilms. J Antimicrob Chemother 2007;59:1130-1134. (Pubitemid 47073323)
36. Whatley WS, Chandra RK, MacDonald CB. Systemic absorption of gentacmicin nasal irrigations. Am J Rhinol 2006;20:251-254. (Pubitemid 44083403)
37. VaughanWC, Carvalho G. Use of nebulized antibiotics for acute infections in chronic sinusitis. Otolaryngol Head Neck Surg 2002;127:558-568. (Pubitemid 36542799)
38. Chiu AG, Palmer JN, Woodworth BA, Doghramji L, Cohen MB, Prince A, Cohen NA. Baby shampoo nasal irrigations for the symptomatic post-functional endoscopic sinus surgery patient. Am J Rhinol 2008;22:34-37. (Pubitemid 351310950)
39. Kaszuba SM, Steward MG. Medical management and diagnosis of chronic rhinosinusitis: a survey of treatment patterns by United States otolaryngologists. Am J Rhinol 2006;20:186-190.
40. Klossek JM, Dubreuil L, Richet H, Richet B, Beutter P. Bacteriology of chronic purulent secretions in chronic rhinosinusitis. J Laryngol Otol 1998;112:1162-1166. (Pubitemid 29004904)
41. Bhattacharyya N, Kepnes LJ. The microbiology of recurrent rhinosinusitis after endoscopic sinus surgery. Arch Otolaryngol Head Neck Surg 1999;125:1117-1120. (Pubitemid 29473375)
42. Bhattacharyya N. Antimicrobial therapy in chronic rhinosinusitis. Curr Allergy Asthma Rep 2009;9:221-226.
43. Lanza DC, Kennedy DW. Adult rhinosinusitis defined. Otolaryngol Head Neck Surg 1997;117:S1-S7. (Pubitemid 27435423)
44. Legent F, Bordure P, Beauvillain C, Berche P. A double blind comparison of ciprofloxacin and amoxicillin/clavulanic acid in the treatment of chronic sinusitis. Chemotherapy 1994;40:8-15. (Pubitemid 24293492)
45. Namyslowski G, Misiolek M, Czecior E, Orecka B, Namyslowski P, Misiolek H. Comparison of the efficacy and tolerability of amoxycillin/clavulanic acid 875 mg b.i.d. with cefuroxime 500 mg b.i.d. in the treatment of chronic and acute exacerbation of chronic sinusitis in adults. J Chemother 2002;14:508-517. (Pubitemid 35346996)
46. Gorwitz RJ, Kruszon-Moran D, McAllister SK, McQuillan G, McDougal LK, Fosheim GE, Jensen BJ, Killgore G, Tenover FC, Kuehnert MJ. Changes in prevalence of nasal colonication with Staphylococcus aureus in the United States, 2001-2004. J Infect Dis 2008;197:1226-1234. (Pubitemid 351632753)
47. Becker SS, Russell PT, Duncavage JA, Creech CB. Current issues in the management of sinonasal methicillin-resistant Staphylococcus aureus. Curr Opin Otolaryngol Head Neck Surg 2009;17:2-5.
48. Bhattacharyya N, Kepnes L. Assessment of trends in antimicrobial resistance in chronic rhinosinusitis. Ann Otol Rhinol Laryngol 2008;117:448-452.
49. Gerencer RZ. Successful outpatient treatment of sinusitis exacerbations caused by community-acquired methicillin-resistant Staphylococcus aureus. Otolaryngol Head Neck Surg 2005;132:828-833. (Pubitemid 40798402)
50. Nixon IJ, Bingham BJ. The impact of methicillin-resistant Staphylococcus aureus on ENT practice. J Laryngol Otol 2006;120:713-717. (Pubitemid 44432906)
51. Solares CA, Batra PS, Hall GS, Citardi MJ. Treatment of chronic rhinosinusitis exacerbations due to methicillin-resistant Staphylococcus aureus with mupirocin irrigations. Am J Otolaryngol 2006;27:161-165.
52. Uren B, Psaltis A, Wormald PJ. Nasal lavage with mupirocin for the treatment of surgically recalcitrant chronic rhinosinusitis. Laryngoscope 2008;118:1677-1680.
53. Grobler A, Weitzel EK, Buele A, Jardeleza C, Cheong YC, Field J, Wormald PJ. Pre- and postoperative sinus penetration of nasal irrigation. Laryngoscope 2008;118:2078-2081.
54. Kobayashi T, Baba S. Topical use of antibiotics for paranasal sinusitis. Rhinol Suppl 1992;14:77-81.
55. Lim M, CitardiMJ, Leong JL. Topical antimicrobials in the management of chronic rhinosinusitis: a systematic review. Am J Rhinol 2008;22:381-389.
56. Amsden GW. Anti-inflammatory effects of macrolides - an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions? J Antimicrob Chemother 2005;55:10-21. (Pubitemid 40192609)
57. Shinkai M, Henke MO, Rubin BK. Macrolide antibiotics as immunomodulatory medications: proposed mechanisms of action. Pharmacol Ther 2008;117:393-405.
58. Yamada T, Fujieda S, Mori S, Yamamoto H, Saito H. Macrolide treatment decreased the size of nasal polyps and IL-8 levels in nasal lavage. Am J Rhinol 2000;14:143-148. (Pubitemid 30441214)
59. Ponikau JU, Sherris DA, Kern EB, Homburger HA, Frigas E, Gaffey TA, Roberts GD. The diagnosis and incidence of allergic fungal sinusitis. Mayo Clin Proc 1999;74:877-884. (Pubitemid 29430354)
60. Shin SH, Ponikau JU, Sherris DA, Congdon D, Frigas E, Homburger HA, Swanson MC, Gleich GJ, Kita H. Rhinosinusitis: an enhanced immune response to ubiquitous airborne fungi. J Allergy Clin Immunol 2004;114:1369-1375. (Pubitemid 39575892)
61. Inoue Y, Matsuwaki Y, Shin SH, Ponikau JU, Kita H. Nonpathogenic, environmental fungi induce activation and degranulation of human eosinophils. J Immunol 2005;175:5439-5447. (Pubitemid 41456430)
62. Ponikau JU, Sherris DA, Weaver A, Kita H. Treatment of chronic rhinosinusitis with intranasal amphotericin B: a randomized, placebo-controlled double-blind pilot trial. J Allergy Clin Immunol 2005;115:125-131. (Pubitemid 40075432)
63. Ebbens FA, Scadding GK, Badia L. Amphotericin B nasal lavages: not a solution for patients with chronic rhinosinusitis. J Allergy Clin Immunol 2006;188:1149-1156. (Pubitemid 44666994)
64. Kennedy DW, Kuhn FA, Hamilos DL, Zinreich SJ, Butler D, Warsi G, Pfister PJ, Tavakkol A. Treatment of chronic rhinosinusitis with highdose terbinafine: a double blind, placebo-controlled study. Laryngoscope 2005;115:1793-1799. (Pubitemid 41475891)
65. Chan KO, Genoway KA, Javer AR. Effectiveness of itraconazole in the management of refractory allergic fungal rhinosinusitis. J Otolaryngol Head Neck Surg 2008;37:870-874.
66. Seiberling K, Wormald PJ. The role of itraconazole in recalcitrant fungal sinusitis. Am J Rhinol Allergy 2009;23:303-306.
67. Rains BM III, Mineck CW. Treatment of allergic fungal sinusitis with high-dose itraconazole. Am J Rhinol 2003;17:1-8. (Pubitemid 36395380)
68. Lal D, Stankiewicz JA. Antifungal treatment and chronic rhinosinusitis. Curr Allergy Asthma Rep 2009;9:227-231.
69. Stevens DA, Schwartz HJ, Lee JY, Moskovitz BL, Jerome DC, Catanzaro A, Bamberger DM, Weinmann AJ, Tuazon CU, Judson MA. A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis. N Engl J Med 2000;342:756-762. (Pubitemid 30151919)
70. Bende M, Fukami M, Arfors KE, Mark J, Stierna P, Intaglietta M. Effect of oxymetazoline nose drops on acute sinusitis in the rabbit. Ann Otol Rhinol Laryngol 1996;105:222-225. (Pubitemid 26090258)
71. Min YG, Kim HS, Suh SH, Jeon SY, Son YI, Yoon S. Paranasal sinusitis after long-term use of topical nasal decongestants. Acta Otolaryngol 1996;116:465-471. (Pubitemid 26183106)
72. Wawrose SF, Tami TA, Amoils CP. The role of guaifenesin in the treatment of sinonasal disease in patients infected with the human immunodeficiency virus (HIV). Laryngoscope 1992;102:1225-1228.
73. Bousquet J, van Cauwenberge PB, Khaltaev N, Aria Workshop Group; World Health Organization. Allergic rhinitis and its impact on asthma: ARIA workshop report. J Allergy Clin Immunol 2001;108:S147-S334.
74. Horak F. Effectiveness of twice daily azelastine nasal spray in patients with seasonal allergic rhinitis. Ther Clin Risk Manag. 2008;4:1009-1022.
75. Bernstein JA. Azelastine hydrochloride: a review of pharmacology, pharmacokinetics, clinical efficacy and tolerability. Curr Med Res Opin 2007;23:2441-2452. (Pubitemid 350033446)
76. Parnes SM. The role of leukotriene inhibitors in patients with paranasal sinus disease. Curr Opin Otolaryngol Head Neck Surg 2003;11:184-191. (Pubitemid 36724365)
77. Jung TTK, Juhn SK, Hwang D, Stewart R. Prostaglandins, leukotrienes, and other arachidonic acid metabolites in nasal polyps and nasal mucosa. Laryngoscope 1987;97:184-188.
78. Bhattacharyya N. Clinical outcomes after endoscopic sinus surgery. Curr Opin Allergy Clin Immunol 2006;6:167-171. (Pubitemid 44510197)
79. Cohen NA, Kennedy DW. Endoscopic sinus surgery: where we are - and where we're going. Curr Opin Otolaryngol Head Neck Surg 2005;13:32-38. (Pubitemid 40194267)
80. Stammberger H, Posawetz W. Functional endoscopic sinus sugery. Concept, indictions and results of the Messerklinger technique. Eur Arch Otorhinolaryngol 1990;247:63-76. (Pubitemid 20102931)
81. Kennedy DW. Functional endoscopic sinus surgery. Technique. Arch Otolaryngol 1985;111:643-649. (Pubitemid 16220409)
82. Chandra RK, Schlosser R, Kennedy DW. Use of the 70-degree diamond burr in the management of complicated frontal sinus disease. Laryngoscope 2004;114:188-192. (Pubitemid 38182608)
83. Vaughan WC. Review of balloon sinuplasty. Curr Opin Otolaryngol Head Neck Surg 2008;16:2-9.
84. Luong A, Patra PS, Fakhri S, Citardi MJ. Balloon catheter dilation for frontal sinus ostium stenosis in the office setting. Am J Rhinol 2008;22:621-624.
85. Stankiewiczz J, Tami T, Truitt T, Atkins J, Liepert D, Winegar B. Transantral, endoscopically guided balloon dilatation of the ostiomeatal complex for chronic rhinosinusitis under local anesthesia. Am J Rhinol Allergy. 2009;23:321-327.
86. Lanza D, Kennedy DW. Balloon sinuplasty: not ready for prime time. Ann Otol Rhinol Laryngol 2006;115:789-790. (Pubitemid 44582876)
87. Khalid AN, Quraishi SA, Kennedy DW. Long-term quality of life measures after functional endoscopic sinus surgery. Am J Rhinol 2004;18:131-136. (Pubitemid 39029209)
88. Metson RB, Gliklich RE. Clinical outcomes in patients with chronic sinusitis. Laryngoscope 2000;110:24-28. (Pubitemid 30140373)
89. Litvack JR, Mace J, Smith TL. Does olfactory function improve after endoscopic sinus surgery? Otolaryngol Head Neck Surg 2009;140:312-319.
90. Chester AC, Sindwani R, Smith TL, Bhattacharyya N. Systemic review of change in bodily pain after sinus surgery. Otolaryngol Head Neck Surg 2008;139:759-765.
91. Loehrl TA, Ferre RM, Toohill RJ, Smith TL. Long-term asthma outcomes after endoscopic sinus surgery in aspirin triad patients. Am J Otolaryngol 2006;27:154-160.
92. Sautter NB, Mace J, Chester AC, Smith TL. The effects of endoscopic sinus surgery on level of fatigue in patients with chronic rhinosinusitis. Am J Rhinol 2008;22:420-426.
93. Bradley DT, Kountakis SE. Correlation between computed tomography scores and symptomatic improvement after endoscopic sinus surgery. Laryngoscope 2005;115:466-469. (Pubitemid 40327994)
94. Levine HL. Functional endoscopic sinus sugery: evaluation, surgery, and follow-up of 250 patients. Laryngoscope 1990;100:79-84. (Pubitemid 20020502)
95. Kennedy DW, Bolger WE, Zinreich SJ. Diseases of the sinuses. 1st ed. Hamilton, Ontario: BC Decker Inc; 2001.